To hear about similar clinical trials, please enter your email below
Trial Title:
A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population
NCT ID:
NCT01569802
Condition:
Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
breast cancer screening
tomosynthesis
FFDM
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Retrospective
Summary:
The primary aim of this study is to measure, document and compare recall rates of
two-dimensional plus three dimensional (2D plus 3D) (Tomosynthesis) mammography to that
of 2D mammography in a screening population. This study will compare recall rates for
both non-cancer and cancer cases.
Criteria for eligibility:
Study pop:
radiology clinic screening population
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Subject is female of any race and ethnicity
- The subject is asymptomatic and presents for routine screening mammography and
chooses to have a combination 2D + 3D mammogram as her standard of care.
Exclusion Criteria:
- Patient chooses standard 2D mammography over a combination 2D + 3D mammogram
Gender:
Female
Minimum age:
30 Years
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
TOPS
Address:
City:
Houston
Zip:
77090
Country:
United States
Status:
Recruiting
Contact:
Last name:
Andra Tidwell, RT(R)(M)
Phone:
281-580-6171
Email:
atidwell@uspi.com
Start date:
January 2012
Lead sponsor:
Agency:
Rose Imaging Specialists, P.A.
Agency class:
Other
Collaborator:
Agency:
Hologic, Inc.
Agency class:
Industry
Source:
Rose Imaging Specialists, P.A.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01569802
